Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma

被引:13
|
作者
Mundada, Pravin [1 ]
Varoquaux, Arthur Damien [2 ]
Lenoir, Vincent [1 ]
de Vito, Claudio [3 ]
Dulguerov, Nicolas [4 ]
Ailianou, Angeliki [1 ,6 ]
Caparrotti, Francesca [5 ]
Becker, Minerva [1 ]
机构
[1] Univ Geneva, Geneva Univ Hosp, Div Radiol, Dept Imaging & Med Informat, Geneva, Switzerland
[2] Aix Marseille Med Univ, Ctr Magnet Resonance Biol & Med, Marseille, France
[3] Univ Geneva, Geneva Univ Hosp, Dept Lab Med Genet & Pathol, Div Clin Pathol, Geneva, Switzerland
[4] Univ Geneva, Geneva Univ Hosp, Dept Clin Neurosci, Clin Otorhinolaryngol Head & Neck Surg, Geneva, Switzerland
[5] Geneva Univ Hosp, Dept Oncol, Div Radiat Oncol, Geneva, Switzerland
[6] Hosp Neuchatel, Dept Imaging, Div Radiol, Neuchatel, Switzerland
关键词
Head and neck squamous cell carcinoma; Post-treatment loco-regional failure; Lymph node recurrence; Diffusion weighted imaging; MRI; POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; RADIATION TREATMENT; FOLLOW-UP; CHEMORADIOTHERAPY; CANCER; TUMORS; RADIOTHERAPY; METAANALYSIS; METASTASIS;
D O I
10.1016/j.ejrad.2018.02.026
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To determine the diagnostic performance of morphologic MRI with diffusion weighted imaging (DWIMRI) for the detection of post-treatment lymph node (LN) recurrence of head and neck squamous cell carcinoma (HNSCC). Methods: This retrospective study is based on 33 HNSCC patients who underwent DWIMRI with apparent diffusion coefficient (ADC) measurements for suspected post-treatment loco-regional failure. Two radiologists, blinded to clinical/histopathological data, analyzed MR images according to established morphologic criteria and measured ADC values by drawing regions of interest on each normal/abnormal looking lymph node (LN). Histopathological findings in 40 neck dissections, 133 LN-levels and 755 LNs served as gold standard. Results: Malignant LNs had lower ADCmean values than benign LNs (1.15 +/- 0.35x10(-3) mm(2)/s versus 1.28 +/- 0.28x10(-3) mm(2)/s, p = .028). The optimal ADCmean threshold to differentiate malignant from benign LNs was 1.1695x10(-3) mm(2)/s. Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values (95% CI in parentheses) of DWIMRI with morphologic criteria and ADCmean<1.1695x10(-3)mm(2)/s were: (a) 100%(86.2; 100), 44.4%(15.3; 77.3), 86.1%(69.7; 94.7), and 100%(39.5; 100) per neck dissection; (b) 83.6%(69.7; 92.2), 91.6%(83.0; 96.2), 85.4%(71.6; 93.4), and 90.5%(81.7; 95.5) per LN-level; (c) 53.1%(43.5; 62.4), 95.5%(93.5; 96.9), 67.4%(56.6; 76.7), and 92.0%(89.6; 93.9) per LN, respectively. Conclusion: The high NPV of DWIMRI irrespective of analysis type (per neck dissection/per neck level/per lymph node) make it a useful follow-up tool after treatment.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 50 条
  • [41] Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI
    Dirix, Piet
    Vandecaveye, Vincent
    De Keyzer, Frederik
    Stroobants, Sigrid
    Hermans, Robert
    Nuyts, Sandra
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (07) : 1020 - 1027
  • [42] Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations
    Ann D. King
    Harriet C. Thoeny
    Cancer Imaging, 16
  • [43] Gene polymorphisms and post-treatment toxicity and treatment response in head and neck squamous cell carcinoma: A scoping review
    Rajabi-Moghaddam, Mahdieh
    Abbaszadeh, Hamid
    ORAL SCIENCE INTERNATIONAL, 2023, 20 (03) : 151 - 164
  • [44] Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations
    King, Ann D.
    Thoeny, Harriet C.
    CANCER IMAGING, 2016, 16
  • [45] Effect of Comorbidity on Post-Treatment Quality of Life Scores in Patients With Head and Neck Squamous Cell Carcinoma
    Gourin, Christine G.
    Boyce, Brian J.
    Vaught, Creighton C.
    Burkhead, Lori M.
    Podolsky, Robert H.
    LARYNGOSCOPE, 2009, 119 (05): : 907 - 914
  • [46] Imaging for the Initial Staging and Post-Treatment Surveillance of Penile Squamous Cell Carcinoma
    Galgano, Samuel J.
    Norton, John C.
    Porter, Kristin K.
    West, Janelle T.
    Rais-Bahrami, Soroush
    DIAGNOSTICS, 2022, 12 (01)
  • [47] Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma
    de Bondt, R. B. J.
    Hoeberigs, M. C.
    Nelemans, P. J.
    Deserno, W. M. L. L. G.
    Peutz-Kootstra, C.
    Kremer, B.
    Beets-Tan, R. G. H.
    NEURORADIOLOGY, 2009, 51 (03) : 183 - 192
  • [48] Clinical Role of Positron Emission Tomography/ Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma
    Abdalla, Abdelrahman Sherif
    Sheybani, Natasha D.
    Khan, Saad A.
    PET CLINICS, 2022, 17 (02) : 213 - 222
  • [49] Pretreatment Diffusion-Weighted and Dynamic Contrast-Enhanced MRI for Prediction of Local Treatment Response in Squamous Cell Carcinomas of the Head and Neck
    Chawla, Sanjeev
    Kim, Sungheon
    Dougherty, Lawrence
    Wang, Sumei
    Loevner, Laurie A.
    Quon, Harry
    Poptani, Harish
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2013, 200 (01) : 35 - 43
  • [50] Emphasizing on heat shock protein 90's utility in head and neck squamous cell carcinoma treatment
    Routray, Samapika
    Sunkavalli, Aparajita
    Swain, Niharika
    Shankar, Akhil A.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2013, 9 (04) : 583 - 586